Cargando…

Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010–2019

INTRODUCTION: Comparisons of healthcare utilization and expenditure among multiple sclerosis (MS) disease-modifying therapies (DMTs) are limited. METHODS: In this retrospective cohort study using commercial insurance claims data of a US population (2010–2019), we compared healthcare utilization and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wen, Tang, Xiaoyu, Heyman, Rock A., Cai, Tianxi, Suh, Kangho, Seeger, John D., Xia, Zongqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338211/ https://www.ncbi.nlm.nih.gov/pubmed/35598225 http://dx.doi.org/10.1007/s40120-022-00358-4

Ejemplares similares

Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data
por: Lee, HyeYeong, et al.
Publicado: (2021)

Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: Analysis of claims-based databases, 2006–2010
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014)

A Survey on Scabies Inpatients in South Korea Based on Health Insurance Claims Data from 2010 to 2019
por: Kim, Hyung-Seon, et al.
Publicado: (2023)

Tuberculosis Test Usage and Medical Expenditures from Outpatient Insurance Claims Data, 2013
por: Owusu-Edusei, Kwame, et al.
Publicado: (2017)

Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
por: Shimizu, Eiko, et al.
Publicado: (2022)

Surgical specialty and preoperative medical consultation based on commercial health insurance claims
por: Thilen, Stephan R., et al.
Publicado: (2018)

Claims-based proxies of patient instability among commercially insured adults with schizophrenia
por: Ruetsch, Charles, et al.
Publicado: (2018)

Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022)

Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data
por: Carroll, Cathryn A, et al.
Publicado: (2014)

Trends in Insurance Coverage for Acupuncture, 2010-2019
por: Candon, Molly, et al.
Publicado: (2022)

SUN-597 Healthcare Utilization Patterns Among Commercially Insured Patients with Prader-Willi Syndrome: A Retrospective Analysis of Administrative Claims
por: Butler, Merlin G, et al.
Publicado: (2020)

Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
por: Zhou, Zhou, et al.
Publicado: (2019)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
por: Hu, Eric, et al.
Publicado: (2023)

Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database
por: Mori, Takahiro, et al.
Publicado: (2022)

Multiple Sclerosis: Pathogenesis and Treatment
por: Loma, Ingrid, et al.
Publicado: (2011)

Weight Loss-Associated Decreases in Medical Care Expenditures for Commercially Insured Patients With Chronic Conditions
por: Thorpe, Kenneth, et al.
Publicado: (2021)

Hospital Claims and the Insurance Surplus
Publicado: (1921)

Effects of capitation payment on utilization and claims expenditure under National Health Insurance Scheme: a cross-sectional study of three regions in Ghana
por: Andoh-Adjei, Francis-Xavier, et al.
Publicado: (2018)

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012)

Systemic overuse of health care in a commercially insured US population, 2010–2015
por: Oakes, Allison H., et al.
Publicado: (2019)

Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan
por: Mori, Takahiro, et al.
Publicado: (2018)

Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018
por: Schwartz, Amy M., et al.
Publicado: (2021)

Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
por: Kern, David M, et al.
Publicado: (2015)

Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes
por: Fitch, Kathryn, et al.
Publicado: (2013)

Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States
por: Gold, Jeremy A. W., et al.
Publicado: (2023)

Correction to: Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan
por: Mori, Takahiro, et al.
Publicado: (2019)

Incidence and Comorbidity of Reactive Attachment Disorder: Based on National Health Insurance Claims Data, 2010–2012 in Korea
por: Hong, Minha, et al.
Publicado: (2018)

Unemployment insurance claims and COVID-19
por: Sjoquist, David, et al.
Publicado: (2021)

Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017
por: Bounthavong, Mark, et al.
Publicado: (2021)

Private dental insurance expenditure in Brazil
por: Cascaes, Andreia Morales, et al.
Publicado: (2018)

Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States
por: Goodin, Douglas S., et al.
Publicado: (2014)

Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)
por: Gold, Laura S., et al.
Publicado: (2016)

Is Fragmented Cancer Care Associated With Medical Expenditure? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data
por: Han, Kyu-Tae, et al.
Publicado: (2023)

Identification of pregnancies and infants within a US commercial healthcare administrative claims database
por: Bertoia, Monica L., et al.
Publicado: (2022)

Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis
por: Stewart, Dan L, et al.
Publicado: (2013)

The Proportion of Uncoded Diagnoses in Computerized Health Insurance Claims in Japan in May 2010 According to ICD-10 Disease Categories
Publicado: (2014)

Measuring 21 low-value hospital procedures: claims analysis of Australian private health insurance data (2010–2014)
por: Chalmers, Kelsey, et al.
Publicado: (2019)

Food and beverage advertising expenditures in Canada in 2016 and 2019 across media
por: Potvin Kent, Monique, et al.
Publicado: (2022)

Frequency and Cost of Claims by Injury Type From the Korea Workers’ Compensation Insurance Between 2016 and 2019
por: Bae, Suk Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_okj168mphrrdq6e9h3gb9e2bvl